Placental histomorphology in unexplained foetal loss with thrombophilia

Indian Journal of Medical Research

Volumn 129, Issue 2, 2009, Pages 144-149

  Vora, S ^a   Shetty, S ^a   Khare, M ^a   Ghosh, Kanjaksha ^a  

^a KEM HOSPITAL   (India)

Author keywords

Antiphospholipid antibodies; Inherited thrombophilia; Recurrent spontaneous abortion

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CYTOSINE; ENDOTHELIAL PROTEIN C RECEPTOR; GUANINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S; PROTHROMBIN; THYMINE;

ADULT; ARTICLE; CALCIFICATION; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS WASTAGE; FIBRIN DEPOSITION; GENE INSERTION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; PATHOGENESIS; PLACENTA DISORDER; THROMBOPHILIA; THROMBOSIS;

ABORTION, SPONTANEOUS; ANNEXIN A5; ANTIBODIES, ANTICARDIOLIPIN; ANTIGENS, CD; ANTITHROMBIN III; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PLACENTA; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; PREGNANCY; PROTEIN C; PROTEIN S; PROTHROMBIN; RECEPTORS, CELL SURFACE; THROMBOPHILIA;

EID: 65949120189     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haematol 2003; 16: 183-95.
2. Branch DW, Silver RM, Blackwell JC. Outcomes of treated pregnancies in women with APS: An update of the Utah experience. Obstet Gynaecol 1992; 80: 614-20.
3. Lubbe WF, Butler WS, Palmer SJ. Foetal survival after prednisolone suppression of maternal lupus anticoagulant. Lancet 1983; 1: 1361-3.
4. Out H, Bruinse HW, Christiaens GCML. A prospective controlled multicentre study on the obstetric risks of pregnant women with APA. Am J Obstet Gynaecol 1992; 167: 26-32.
5. Branch DW, Porter TF, Rittenhouse L. Antiphospholipid antibodies in women at risk for pre eclampsia. Am J Obstet Gynaecol 2001; 184: 823-34.
6. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel Viper Venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-74.
7. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-51.
8. Sambrook J, Fritsch EF, Manniatis T. Molecular cloning: A laboratory Manual 1989, Cold Spring Harbor Laboratory Press.
9. Arruda VR, Annichinos-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common Brazilian population. Am J Haematol 1995; 49: 242-3.
10. Poort SR, Rosendaal R, Leitsma PH, Bertina RM. A common genetic variation in the 3′ translocated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
11. Abbate R, Sardi I, Pepe, Marcucci R, Brunelli T, Prisco, et al. The high prevalence of thermolabile 5-10 methylene tetrahydrofolate reductase risk for coronary artery disease (CAD). Thromb Haemost 1998; 79: 727-38.
12. Akar N, Gokdemir R, Ozel D, Akar E. Endothelial protein C receptor (EPCR) gene 23bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost 2002; 88: 1068-9.
13. Morange PE, Henry M, Tregou Et D, Granel B, Aillaud MF, Alessi MC, et al. The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in Factor V Leiden carriers. Arterioscler Thromb Vasc Biol 2000; 20: 1387-91.
14. Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal SLE with antiphospholipid syndrome; a case report and review of literature. Hum Pathol 1996; 27: 201-6.
15. Salafia CM, Cowchock FS. Placental pathology and antiphospholipids: a descriptive study. Am J Perinatol 1997; 14: 435-41.
16. Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Clin Rheum Dis 1997; 23: 85-97.
17. Magid MS, Kaplan C, Sammaritano LR, Peterson M, Druzin ML, Lockshin MD. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998; 179: 226-34.
18. Levy RA, Avvad E, Oliveira J, Proto LC. Placental pathology in antiphospholipid syndrome. Lupus 1998; 7: S81-5.
19. Wang X, Campos B, Kaezel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynaecol 1999; 180: 1008-16.
20. Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y. Placental pathology in SLE with antiphospholipid antibodies. Pathol Int 2000; 50: 224-9.
21. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000; 15: 1830-3.
22. Yacobi S, Ornoy A, Blumenfeld Z, Miller RK. Effect of sera from women with SLE or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratol 2002; 66: 300-8.
23. Sikkema JM, Franx A, Bruinse HW, Van der Wijk NG, de Valk HW, Nikkels PG. Placental pathology in early onset preecclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002; 23: 337-42.
24. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002; 109: 570-3.
25. Sebire NJ, Backos M, Gaddal El, Goldin RD, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003; 101: 258-63.
26. Younis JS, Samueloff A. Gestational vascular complications. Best Pract Res Clin Haematol 2003; 16: 135-51.
27. Svensson AM, Waters BL, Laszik ZG, Simmons Arnold L, Goodwin A, Beatty BG, et al. The protein C system in placental massive perivillous fibrin deposition. Blood Coagul Fibrinol 2004; 15: 491-5.
28. Van Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid like syndromes. Placenta 2004; 25: 642-8.
29. Verspyck E, Marpeau L. Thrombophilia and vascular placental pathology. A survey of literature. Rev Med Intern 2005; 26: 103-8.
30. Francis J, Rai R, Sebire NJ, El-Gladdal S, Fernandes MS, Jindal P, et al. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with RPL associated with antihospholipid syndrome. Mol Hum Reprod 2006; 12: 435-42.
31. Bernirschke K. A review of the pathologic anatomy of the human placenta. Am J Obstet Gynaecol 1962; l84: 1595-622.
32. Dizon T, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997; 34: 217-23.
33. Fox H, Bennington JL. Major problems in pathology. Philadelphia: WB Saunders; 1978. p. 95-148.
34. Parke A, Maier D, Hakim C. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rhematol 1986; 13: 1178-80.
35. Bajaj MS, Kupper Swamy MN, Mane Palli AN, Bajaj SP. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and Von Willibrand factor in normal human tissues. Thromb Haemost 1999; 82: 1047-52.